Non-hormonal vaginal contraceptive
View Patent ↗The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present invention also relates to methods of contraception using such a device, as well as the prevention and treatment of sexually transmitted diseases and vaginal infections through the application of the device.
1. An intravaginal contraceptive device, comprising:
a biocompatible and biodegradable polymeric support structure having an annular shape surrounding an opening, constructed and configured to be inserted into a mammal's vagina, the support structure constructed and formed of materials such that the structure is capable of remaining in a vagina for three days, while degrading, but without dissolving completely, the polymeric support structure comprising poly-DL-lactide;
a non-hormonal spermicidal and/or spermiostatic composition disposed within the support structure, said composition comprising at least one spermiostatic/spermicidal agent selected from the group consisting of magnesium chloride, calcium chloride, ferrous sulfate, copper sulfate and ferrous gluconate;
the support structure with the composition disposed therein, constructed and formed of materials effective to break down, while in the vagina, and thereby provide sustained release of a spermicidally or spermiostatically effective amount of the composition for three days, wherein the composition comprises an effective amount of ascorbic and/or a derivative thereof to increase the viscosity of cervical mucus after it is inserted into a mammal's vagina.
2. The device of claim 1 , wherein the composition comprises an agent, in the presence of which the viscosity of cervical mucus increases.
3. The device of claim 1 , wherein the composition comprises a pH limiting component in an effective amount to prevent the pH in a vagina from increasing in the presence of semenal fluid.
4. The device of claim 1 , wherein the composition comprises a biocompatible organic acid.
5. The device of claim 1 , wherein the composition comprises a polyamino acid or a polycarboxylic acid or combinations thereof.
6. The device of claim 1 , wherein the composition comprises ascorbic acid and/or a derivative thereof; and a polyamino acid and/or a polycarboxylic acid or combinations thereof.
7. The device of claim 6 , wherein the device is in a ring-like configuration.
8. The device of claim 6 , wherein the support structure comprises a convoluted shape.
9. The device of claim 1 , wherein the support structure with the composition disposed therein is constructed and formed of materials effective to provide sustained release of said effective amount of the composition for 7 days.
10. The device of claim 1 , wherein the support structure with composition disposed therein is constructed and formed of materials effective to provide sustained release of said effective amount of the composition for 16 days.
11. The device of claim 1 , wherein the support structure with composition disposed therein is constructed and formed of materials effective to provide sustained release of said effective amount of the composition for 28 days.
12. The device of claim 1 , wherein the device comprises effective amounts of material to maintain a pH of about 4-5 in a vagina during the sustained release of said composition, in the presence of semenal fluid.
13. The device of claim 1 , wherein the composition comprises ferrous gluconate.
14. The device of claim 1 , wherein the support structure comprises hydrogel material.
15. The device of claim 1 , wherein the support structure comprises at least one of dextran-maleic acid, dextran-acrylate, dextran-allyl isocyanate, polyglycolide, polylactide, co-polymers of polyglycolide or polylactide, or combinations thereof.
16. The device of claim 1 , wherein the support structure comprises a ring shape.
17. The device of claim 1 , wherein the support structure comprises a plurality of layered polymer sheaths.